Review, reevaluation, and new results in quantitative structure‐activity studies of anticonvulsants
暂无分享,去创建一个
[1] J. Quail,et al. (Aryloxy)aryl semicarbazones and related compounds: a novel class of anticonvulsant agents possessing high activity in the maximal electroshock screen. , 1996, Journal of medicinal chemistry.
[2] A. Leo,et al. Hydrophobicity and central nervous system agents: on the principle of minimal hydrophobicity in drug design. , 1987, Journal of pharmaceutical sciences.
[3] J. Ferrendelli,et al. Synthesis and structure-activity studies of alkyl-substituted gamma-butyrolactones and gamma-thiobutyrolactones: ligands for the picrotoxin receptor. , 1991, Journal of medicinal chemistry.
[4] T. Latifi,et al. Synthesis and Anticonvulsant Activities of 3,3-Dialkyl- and 3-Alkyl-3-benzyl-2-piperidinones (δ-Valerolactams) and Hexahydro-2H-azepin-2-ones (ε-Caprolactams) , 1997 .
[5] Albert J. Leo,et al. [25] Hydrophobic parameter: Measurement and calculation , 1991 .
[6] D. Hirschfeld,et al. 1-(Naphthylalkyl)-1H-imidazole derivatives, a new class of anticonvulsant agents. , 1981, Journal of medicinal chemistry.
[7] A. Leo. CALCULATING LOG POCT FROM STRUCTURES , 1993 .
[8] T. Lynes,et al. THE ANTICONVULSANT PROPERTIES OF SOME SUBSTITUTED BENZAMIDES. , 1963, Journal of medicinal chemistry.
[9] A M Triggle,et al. 1,4-Dihydropyridine antagonist activities at the calcium channel: a quantitative structure-activity relationship approach. , 1988, Journal of medicinal chemistry.
[10] W. S. Koski,et al. Physicochemical, Quantum Chemical, and Other Theoretical Techniques for the Understanding of the Mechanism of Action of CNS Agents: Psychoactive Drugs, Narcotics, and Narcotic Antagonists and Anesthetics , 1975 .
[11] C. Hansch,et al. The parabolic dependence of drug action upon lipophilic character as revealed by a study of hypnotics. , 1968, Journal of medicinal chemistry.
[12] D. Ortwine,et al. Substituted 2-benzothiazolamines as sodium flux inhibitors: quantitative structure-activity relationships and anticonvulsant activity. , 1994, Journal of pharmaceutical sciences.
[13] H. Hara,et al. Novel 4-substituted 2-piperazinylquinazolines as potent anticonvulsive and antihypoxic agents. , 1990, Chemical & pharmaceutical bulletin.
[14] G. Webb,et al. Electronic factors in the structure-activity relationship of some 1,4-benzodiazepin-2-ones. , 1977, Journal of medicinal chemistry.
[15] A. Verloop,et al. Development and Application of New Steric Substituent Parameters in Drug Design , 1976 .
[16] W. Klunk,et al. Comparison of epileptogenic properties of unsubstituted and beta-alkyl-substituted gamma-butyrolactones. , 1982, Molecular pharmacology.
[17] A. Leo,et al. Substituent constants for correlation analysis in chemistry and biology , 1979 .
[18] C. R. Clark,et al. Anticonvulsant activity of some 4-aminobenzamides. , 1984, Journal of medicinal chemistry.
[19] H. Hara,et al. Novel 4-phenoxy-2-(1-piperazinyl)quinazolines as potent anticonvulsive and antihypoxic agents. , 1990, Chemical & pharmaceutical bulletin.
[20] J. Ferrendelli,et al. Convulsant and anti-convulsant gammabutyrolactones bind at the picrotoxinin/T-butylbicyclophosphorothionate (TBPS) receptor. , 1985, Biochemical pharmacology.
[21] J. Ferrendelli,et al. Alpha-spirocyclopentyl- and alpha-spirocyclopropyl-gamma-butyrolactones: conformationally constrained derivatives of anticonvulsant and convulsant alpha,alpha-disubstituted gamma-butyrolactones. , 1994, Journal of medicinal chemistry.
[22] H. Keasling,et al. The relationship between structure and anticonvulsant activity in a series of benzenesulfonamides. , 1965, Journal of medicinal chemistry.
[23] Y. Takahata,et al. Quantitative Structure-Activity Relationships for 1,4-Dihydropyridine Calcium Channel Antagonists (Nifedipine Analogues): A Quantum ChemicalKlassical Approach , 1994 .
[24] J. Yamada,et al. A quantitative structure-activity study of anticonvulsant benzyl N,N-dimethylcarbamates. , 1982, Chemical & pharmaceutical bulletin.
[25] C. Hansch. Quantitative approach to biochemical structure-activity relationships , 1969 .
[26] A. Soloway,et al. Penetration of brain and brain tumor by aromatic compounds as a function of molecular substituents. , 1960, The Journal of pharmacology and experimental therapeutics.
[27] Corwin Hansch,et al. A survey of Hammett substituent constants and resonance and field parameters , 1991 .
[28] C. Hansch,et al. QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIPS OF THE BENZODIAZEPINES. A REVIEW AND REEVALUATION , 1994 .
[29] H. Blaschko. Inhibition in the nervous system and gamma-aminobutyric acid: (E. Roberts: Editor) Pergamon Press, Ltd., Oxford, 1960, 600 pp, 100s. , 1961 .
[30] C. Hansch,et al. Lipophilic character and biological activity of drugs. II. The parabolic case. , 1973, Journal of pharmaceutical sciences.
[31] S. P. Gupta,et al. QSAR studies on drugs acting at the central nervous system , 1989 .
[32] E. Lien. Structure-activity correlations for anticonvulsant drugs. , 1970, Journal of medicinal chemistry.
[33] C. Hansch,et al. Quantitative structure-activity relationships of cytochrome P-450. , 1993, Drug metabolism reviews.
[34] E. Lien,et al. Quantitative structure-activity relationships and dipole moments of anticonvulsants and CNS depressants. , 1979, Journal of pharmaceutical sciences.
[35] G. Glaser,et al. Antiepileptic drugs : mechanisms of action , 1980 .
[36] G. L. Tong,et al. Structural requirements for centrally acting drugs. I. , 1973, Journal of pharmaceutical sciences.